CIAM
PMVP icon

Caitong International Asset Management’s PMV Pharmaceuticals PMVP Stock Holding History

Caitong International Asset Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24 Buy
18
+15
+500% +$19 ﹤0.01% 2491
2026
Q1 		$4 Buy
+3
New +$4 ﹤0.01% 2344
2025
Q4 		– Sell
-20
Closed -$28 – 2275
2025
Q3 		$28 Buy
+20
New +$28 ﹤0.01% 1836

Other funds holding PMVP

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Caitong International Asset Management's PMVP Position: Q2 2026 in Review

Caitong International Asset Management increased its PMV Pharmaceuticals (PMVP) stake by 500% in Q2 2026, buying an estimated $19 and bringing the position to 18 shares worth $24. The position accounts for ﹤0.01% of the portfolio, ranked #2491.

Caitong International Asset Management first reported a position in PMVP in Q3 2025 and has held it in 3 quarters since. The position peaked at $28 in Q3 2025. 5 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • Caitong International Asset Management held 18 shares of PMV Pharmaceuticals worth $24 as of Q2 2026.
  • Caitong International Asset Management bought 15 PMV Pharmaceuticals shares in Q2 2026, an estimated $19.
  • PMV Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2491 holding.
  • Caitong International Asset Management first reported a position in PMV Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Caitong International Asset Management's PMV Pharmaceuticals position peaked at $28 in Q3 2025.
  • 5 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.